177 related articles for article (PubMed ID: 2417564)
1. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
[TBL] [Abstract][Full Text] [Related]
2. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
[TBL] [Abstract][Full Text] [Related]
3. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
5. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
Fujii M; Okabe K; Ishikawa M; Toki H; Fujita Y; Araki Y
Gan To Kagaku Ryoho; 1984 Feb; 11(2):265-9. PubMed ID: 6198968
[TBL] [Abstract][Full Text] [Related]
7. [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
Nakabayashi T; Yasuda S; Miyamoto H; Abe S; Ohosaki Y
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2998-3004. PubMed ID: 2429619
[TBL] [Abstract][Full Text] [Related]
8. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR
Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751
[TBL] [Abstract][Full Text] [Related]
9. [CDDP-containing combination chemotherapy for advanced lung cancer].
Asamoto H; Hisa T; Sawano T; Sakai K; Kitamura S; Matsushita N; Kokura M; Satake H; Kawakami I
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2544-9. PubMed ID: 6210053
[TBL] [Abstract][Full Text] [Related]
10. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
Whitehead RP; Rosenbaum PR; Carbone PP
Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy in squamous cell carcinoma of the lung.
Krzakowski MJ; Swierz J
Chemioterapia; 1984 Apr; 3(2):75-8. PubMed ID: 6085285
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Miyake M; Hiraki Y; Douke T; Kashitani N; Kondou S; Kimoto S; Hashimoto K; Aono K; Tanaka N; Inoue F
Rinsho Hoshasen; 1988 Jan; 33(1):35-40. PubMed ID: 2452907
[No Abstract] [Full Text] [Related]
18. Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lung.
Morris RW; Brubaker LH; Kardinal CG; Carolla RL; Perry MC
Cancer Clin Trials; 1979; 2(1):37-41. PubMed ID: 229982
[TBL] [Abstract][Full Text] [Related]
19. [Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
Nishimura M; Sugiura T; Urata A; Ota K
Gan To Kagaku Ryoho; 1985 Jan; 12(1):54-60. PubMed ID: 2578274
[TBL] [Abstract][Full Text] [Related]
20. [Cisplatin, adriamycin and VP-16 (CAV) in the treatment of small cell carcinoma of the lung].
Yokoyama A; Kinameri K; Kurita Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2573-8. PubMed ID: 6095762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
